UNIVERSITY OF ALABAMA AT BIRMINGHAM
Clinical Implementation of Blood Pressure Polygenic Risk Score: A Randomized Clinical Trial
Clinical Implementation of Blood Pressure Polygenic Risk Score: A Randomized Clinical Trial is a funding opportunity from UNIVERSITY OF ALABAMA AT BIRMINGHAM, up to 726809, closing May 31, 2030.
May 31, 2030
(1400d left)Overview
Elevated blood pressure (BP) is the single greatest modifiable contributor to premature mortality globally. The development of hypertension (HTN) and associated adverse cardiovascular (CV) events is contributed by an interplay of genetic and environmental factors. We constructed a genome-wide systolic BP (SBP)…